| 內容註: |
Preface by Prof Myron Christodoulides, University of Southampton, UK -- 1. Introduction chapter on the VALIDATE network -- (Prof Helen McShane, Director Oxford NIHR Biomedical Research Centre, University of Oxford, UK and Samantha Vermaak, The Jenner Institute Laboratories, Oxford, UK) -- Part I: Leprosy -- 2. Leprosy challenges to vaccine developers -- (Dr Hua Wang, University of Glasgow, UK) -- 3. Leprosy vaccine development -- (Dr Khushboo Borah, University of Surrey, UK) -- Part II: Tuberculosis -- 4. Biomarkers in tuberculosis vaccine development -- (Dr Kenneth Akwue, University of the Witwatersrand, Johannesburg, South Africa) -- 5. Tuberculosis correlates of protection (Dr Rachel Tanner, The Jenner Institute Laboratories, Oxford, UK), -- Animal models for tuberculosis (Dr. Hao Li, China Agricultural University, Beijing, China) -- 7. BCG vaccination -- (Dr Hazel Morrison, The Jenner Institute Laboratories, Oxford, UK) -- 8. Vaccination strategies for Buruli ulcer disease (Dr Rachel Simmonds, University of Surrey, UK) -- 9. Fermentation in vaccine development (BCG) (Dr. Joanna Bacon, Public Health England, UK Government, London, UK) -- Part III: Leishmaniasis: 10. Human leishmaniasis vaccination -- (Dr Ali Bordbar, Institute Pasteur of Iran, Tehran, Iran) -- 11. Aspects of human leishmaniasis vaccine use -- (Dr Olayinka Osuolale, Elizade University, Ilara-Mokin, Nigeria) -- 12. Human challenge model for developing leishmaniasis vaccines (Prof Paul Kaye, University of York, UK) -- 13. Canine leishmaniasis vaccines -- (Prof Eduardo Coelho, Federal University of Minas Gerais, Belo Horizonte, Brazil and Prof Myron Christodoulides, University of Southampton, UK) -- Part IV: Melioidosis -- 14. Vaccines for melioidosis (Prof Chiranjay Mukhopadhyay, Kasturba Medical College, Manipal, India) -- 15. West Africa burden of disease (Dr Tukur Ismail, Zamfara State Primary Healthcare Board, Gusau, Nigeria) |